Pharmaceuticals are a group of
organic compounds that can be utilized for diagnosis, treatment, or prevention
of a disease and for restoring any organic function. Most of the pharmaceutical
products are proteins or polypeptides which can either be obtained naturally or
can be extracted from genetically modified microorganisms. Generally, these
products are delivered to the patients in the solid form such as tablets or
aerosols. Israel pharmaceuticals market is ranked as fourth largest supplier of
pharmaceutical products in the world due to its high financial investment in
research and development (R&D) of pharmaceutical products and impressive
international reach. Rising prevalence of various non-communicable diseases
especially cancer, diabetes, and cardiac disorders among people of the country
is likely to register an impressive growth to Israel pharmaceuticals Market.
Government of Israel is developing its focus on conducting more health
education programs along with formation of new health insurance policies every
year which is influencing people to take proper care of their health and is
thereby progressing the pharmaceuticals market in the country. Moreover, growth
in geriatric population of the country and various health problems associated
with people in their old age is expected to propel the growth of Israel pharmaceuticals
market.
Growing Prevalence of Chronic Diseases
Chronic illness is broadly
defined as a disease which lasts more than a year and require ongoing medical
attention which simultaneously limits the activities of a person in daily life.
Chronic diseases such as diabetes, cancer and cardiac disorders are some of the
majorly prevailing diseases among the people of the country, accounting for
about 20 percent of the total population of Israel suffering from one or more
of the selected diseases. It has been observed that cancer is the most
prevailing cause of rising death rate in Israel. Every year around 30,000
people get diagnosed with cancer which is the reason behind 25% of the total
mortality each year. As per the report published by World Health
Organization (WHO) in 2020, it has been observed that total 14,197 cases were
reported of cancer in Israel men among which accounted for 3,290 cases of
prostate cancer, 1,613 cases of lung cancer, 1,490 cases of colorectum cancer,
and so on. Moreover, a total of 14,507 cancer cases were reported in Israel
women out of which 4,348 cases were of breast cancer, 1,392 cases of colorectum
cancer, 1,029 cases of thyroid cancer, and so on. Various habits such as smoking
cigarettes, consuming alcohol, eating unhealthy diet, hypertension, and others
are some of the major risk factors which lead to the development of heart
diseases in human body. According to the report published by AHA Journal in
2020, it has been observed that cardiovascular disease is the second cause
behind mortality and morbidity rate of Israel in recent years which accounts
for almost 15% of the total number of deaths per year. Moreover, cardiac disease
affects 10.2% of Israeli men and 7.1% of women, with coronary artery disease
prevalence of 7.5% and 4.1%, respectively. Diabetes is also one of the most
commonly prevailing non-communicable disease in Israel. Among the two types of
diabetes, Type 2 diabetes mellitus is more usual than Type 1 diabetes among
people of the country. Significant factors which are associated with the growth
of Type 2 diabetes in Israel are physical inactivity of people, genetic
disorders, obesity, and growing age of people. According to a study
conducted by Bentham Science in 2021, it has been resulted that in Arab society
of Israel, prevalence of Type 2 diabetes mellitus increased from 3.4% to 7.6%
which is expected to increase continuously and is predicted to go above 12% by
2030. Emerging cases of chronic disease in Israel is leading to increase in
purchase of various pharmaceutical products in every region of Israel which
will bolster the growth of Israel pharmaceuticals market in the forecast
period.
Download Free Sample Report
Rise in Health Education Programs
and Government Initiatives
Government of Israel is taking
numerous initiatives to spread the importance of healthcare among people by organizing
various healthcare education programs in every region of the country. The Israeli Health Promoting School Network (HPSN) is actively
committed to enhance healthy lifestyle for the entire school population.
Moreover, the government is mainly emphasizing on controlling the bad lifestyle
habits of citizens such as smoking cigarettes, overeating, lack of physical
exercising, and others which are the primary causes of several long-lasting
diseases in human body. Government is making technological advancements in
healthcare systems and is dedicated to improving their research and development
for producing new pharmaceutical product which may assist people to get rid of
their unhealthy habits. These many initiatives taken by the government to
upgrade their healthcare facilities is further expected to propel the growth of
Israel pharmaceuticals market in upcoming years.
Introduction of Health Insurance
Policies
Israel has one of the most
advanced and highest quality healthcare systems in the world and is ranked at
tenth position globally due to its affordable healthcare system. According to
the National Health Insurance law every Israeli citizen is entitled to health
care services. It makes the purchase of medicines and various other
pharmaceutical products more affordable for people which is fueling the growth
of Israel pharmaceutical market.
Growth in Geriatric Population
In Israel, approximately around 1,056,300
people are above 65 years of age which account for almost 11.8% of the total
population. With ageing, people tend to develop more chances of getting
diagnosed with various chronic diseases more frequently. Cardiac disorder is
the most prominent problem in Israel which is prevailing more commonly among
geriatric population and deteriorating their health. According to the report
published by AHA Journal in 2020, around 42% of men and 31% of women who were
above 75 years of age, were resulted suffering from severe cardiac illness.
Moreover, in Israel, about 25,000 people are hospitalized for myocardial
infarction each year. 43,000 patients undergo coronary angiography and 23,000
undergo percutaneous coronary intervention each year. In most cases, the
situation is the same as in diagnostic procedures, but about 50% occur during
hospitalization for acute coronary syndrome (ACS).3 The ratio of percutaneous
coronary intervention to coronary artery bypass surgery is 8:1 which is one of
the highest in the world. Several other diseases affect the aged people due
to their lower immunity and unhealthy lifestyle, which is expected to boost the
growth of Israel pharmaceuticals market in upcoming years.
Recent Developments
- Pharmaceutical
giant Pfizer Pharmaceuticals Israel Ltd. has invested USD 20 million in Israeli
firm CytoReason, a developer of computational disease models for drug research
and development, as part of a larger deal worth up to USD 110 million over the
next five years. The agreement builds on an
existing multi-year collaboration agreement signed in 2019, allowing Pfizer to
leverage CytoReason's digital models of the human immune system and disease for
the development of innovative medicines.
- Doxil (known as
Caelyx in Europe and Canada) is the world's first nanodrug to treat various
types of cancer, developed by researchers at the Hebrew University of
Jerusalem. The Weizmann Institute of Science has developed Copaxone, a
breakthrough drug for the treatment of multiple sclerosis. This is one of the
first Israeli drugs to get approved by U.S. Food and Drug Administration. In
recent decades, Israel has become an important part of the global
pharmaceutical industry, with exports to the United States alone rising from USD
208 million in 1997 to USD 5.9 billion in 2018.
Israel pharmaceuticals market
is segmented based on drug type, product type, application, distribution
channel, company, and region. Based on drug type, the pharmaceutical market is
categorized into generic drugs and branded drugs. Based on, product type,
market is divided into over-the-counter drugs and prescription drugs. Based on
application, pharmaceutical market is segmented into cardiovascular, oncology,
metabolic disorder, musculoskeletal, anti-infective, and others. Based
on distribution channel market is fragmented into retail pharmacy, hospital
pharmacy, and e-pharmacy.
Market Players
Teva Pharmaceutical
Industries Ltd, Kamada Pharmaceuticals, MediWound Ltd, Protalix BioTherapeutics
Inc, Enlivex Therapeutics Ltd, Bonus BioGroup Ltd, Roche Pharmaceuticals
(Israel) Ltd., and Rafa Laboratories Ltd. are some of the key market players in
the market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024-2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume in Tons,
and CAGR for 2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue
forecast, volume forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
Drug Type
Product Type
Application
Distribution Channel
|
|
Regional scope
|
The
Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, and The
Negev Desert
|
|
Key companies profiled
|
Teva Pharmaceutical Industries Ltd,
Kamada Pharmaceuticals, MediWound Ltd, Protalix BioTherapeutics Inc, Enlivex
Therapeutics Ltd, Bonus BioGroup Ltd, Roche Pharmaceuticals (Israel) Ltd.,
Rafa Laboratories Ltd.
|
|
Customization
scope
|
10% free report
customization with purchase. Addition or alteration to country, regional
& segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can
also provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, Israel pharmaceuticals market has been segmented
into following categories, in addition to the industry trends which have also
been detailed below:
Pharmaceuticals Market, By Drug Type:
- Generic and Branded Drugs
Pharmaceuticals Market, By Product Type:
- Over-The-Counter Drugs
- Prescription Drugs
Pharmaceuticals Market, By Application:
- Cardiovascular
- Oncology
- Metabolic Disorder
- Musculoskeletal
- Anti-infective
- Others
Pharmaceuticals Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
Competitive Landscape
Company Profiles: Detailed analysis
of the major companies present in Israel pharmaceuticals market.
Available
Customizations:
With
the given market data, TechSci Research offers customizations according to a
company’s specific needs. The following customization options are available for
the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Israel
pharmaceuticals market is an upcoming report to be released soon. If you wish
an early delivery of this report or want to confirm the date of release, please
contact us at [email protected]